Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A.
American National Red Cross, Washington, DC, United States
Search 3 grants from Todd Hembrough
Search grants from American National Red Cross
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Preclinical development of semisynthetic saponin immunological adjuvant Titerquil-1055 in the context of an influenza vaccine
Mitochondrial Respiratory Control Using NMR and Transgenic Mice
Antigenic Analysis of Dengue Virus Envelope Protein Subunit Vaccines
Surveillance Epidemiology and End Results
Regulation of Laminin Genes by Retinoids
Recently added grants:
Identification and development of antimicrobial peptoids effective against cross-kingdom biofilms
Genome-wide CRISPR/Cas9-mediated loss-of-function screens to identify Toxoplasma genes that determine fitness in gamma interferon-stimulated human cells
Genetic and mechanistic analysis of carbon dioxide tolerance in Cryptococcus pathogenesis
Human Genetic determinants of HBV recovery
A novel approach for deep phenotyping the CD4 T cell response to Mycobacterium Tuberculosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32HL009910-02
Application #
2838876
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1998-12-01
Project End
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Related projects
NIH 2000
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
$21,616
NIH 1999
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
NIH 1998
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
Publications
Hembrough, T A; Ruiz, J F; Papathanassiu, A E et al.
(2001)
Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor.
J Biol Chem 276:12241-8
Comments
Be the first to comment on Todd Hembrough's grant